Sitemap - 2022 - BowTiedBiotech
BowTiedBiotech's Top 10 Most-Read Stories in 2022
Epoch 52 - Closing Out Biotech 2022
Epoch 51 - Special Delivery: Exosome Overview
Epoch 51 - Grading 2022 Predictions & Making a Few For 2023
Epoch 50 - How Biotech Companies That Lose Money are Worth Billions
Epoch 50 - Biotech Rises From the ASHES
🚨 LAUNCH ANNOUNCEMENT: LIFE SCIENCE CAREER GUIDE: REJECT REJECTION $22
Epoch 49 - Inflation Reduction Act: Make Them an Offer They Can’t Refuse
BowTiedBiotech Holiday Gift Guide
Epoch 49 - Biotech Santa Claus Rally Remains Elusive
Epoch 48 - Biotech Startups & Licensing Intellectual Property
Epoch 48 - Biotech Chess not Checkers
Epoch 47 - 5 Key Post-Thanksgiving Biotech Themes
Epoch 47 - Happy Birthday BowTiedBiotech!
Epoch 46 - Benchmarking the Big Boys: Biotech Venture Capital Rankings
Epoch 46 - Following the Biobucks into 2023
Epoch 45 - Precision TechBio - The Time is Now?
Epoch 45 - The Fall Stall Hits Biotech
Epoch 44 - Pharma vs Biotech - Which Does R&D Better?
Epoch 44 - Encouraging Week from Biotech, Despite FED Wrecking Ball
Epoch 43 - EVERYTHING You Need to Understand About BIG Pharma Venture Capital
Epoch 43 - Why This Week’s Biotech Bounce is Fake
Epoch 42 - A Trojan Horse Enters With MASSIVE Biotech Implications
Epoch 42 - Biotech Recovery On Hold?
Epoch 41 - What do Biotech & Hollywood Have in Common?
Epoch 41 - Biotech M&A Targets Crystallize
Epoch 40 - Which Pharma R&D Unit is Most Productive?
Epoch 40 - Biotech Super Tuesday
Epoch 39 - Sorry But...Biotech Does Not Scale
Epoch 39 - Biotech Light Flickers in Darkness
Epoch 38 - Why Top Tier Academic Research Funding Isn't Fair
Epoch 38 - Hurricane Season Hits Biotech
Epoch 37 - Why Invest in Decentralized Science?
Epoch 37 - No Biotech IPO, No Place to Go?
Epoch 36 - Creating Quality Shots on Goal for Biotech Success
Epoch 36 - Over 75% of Biotech Participants Believe Biotech Will End the Year Higher?
🚨 LAUNCH ANNOUNCEMENT: BowTiedBiotech Consulting Services
Epoch 35 - The Coming FED Pivot is NOT What You Expect
Epoch 35 - A Minnow Sized Deal With Whale Sized Implications
Epoch 34 - AZ & Pfizer Score at the Top of Recent Research & Development Rankings
Epoch 34 - The Most Active Biotech Venture Capital Firms of 2022
Epoch 33 - Why Merck is Paying a Small Biotech $3.5B for Access to Circular RNA Technology
Epoch 33 - Reeling in BIG Biotech Deals
Epoch 32 - Medical Device Biotech
Epoch 32 - Hot Capital is Back in Biotech?
Epoch 31 - Introducing R&D MegaFunds
Epoch 31 - Data & Deals Propel Biotech
Epoch 30 - No More Small Molecule Medicines from Biotech?
Epoch 30 - Monetary Policy Shell Games to Lead a Biotech Recovery
Epoch 29 - Forecasting a Biotech Return to Normalcy
Epoch 29 - Biotech Bounce - A Rigged Rally?
Epoch 28 - How to Get Hired in Biotech
Epoch 28 - Biotech Injured, But not Out?
Epoch 27 - Decoding Long COVID
Epoch 26 - The Dirty Term Sheet
Epoch 26 - The Biotech Summer of Love?
Epoch 25 - Biotech an 'Uninvestable' Sector
Epoch 25 - Investors Nibbling at DeRisked Biotech
Epoch 24: Deactivating Biotech Activists
Epoch 24 - Biotech Managed Decline
Epoch 23 - ASCO: 3 Key Takeaways
Epoch 23 - Biotech Hidden Gems
Epoch 22 - The Biotech Crucible Moment
Epoch 21 - Network Effects for Biotech
Epoch 21 - Unpacking the Biotech Capital Supply Chain
Epoch 20 - Highlights from the American Society of Gene and Cell Therapy (ASGCT) Meeting
Epoch 20 - Biotech Blood in the Street
Epoch 18 - Beyond Therapeutics: The BIO-REVOLUTION
Epoch 17 - R&D Budget Setting Mechanics
Epoch 16 - Decentralized Science - DeSci
Epoch 16 - Biotech Continues its Negative Trajectory
Epoch 15 - 2022 American Association for Cancer Research (AACR) Recap
Epoch 15 - Biotech: Get Paid or Die Trying
Epoch 14 - LifeStyle Drugs Coming from Biotech?
Epoch 14 - Biotech Crab Market
Epoch 13 - Phenotype of the Perfect Biotech Builder
Epoch 13 - Biotech - We Are Going To Make It
Epoch 12 - Negotiating for BIOBUCKS
Epoch 12 - Biotech Are We In the Eye of the Storm?
Epoch 11 - Building Biotech - A System for Raising Venture Financing
Epoch 11 - Biotech Full Body Scan
Epoch 10 - Biotech - Half Empty or Half Full?
Epoch 9 - European Biotech - Ready for Lift Off
Epoch 9 - Biotech GroundHog Day
Epoch 8 - BioBlack Swan from Ukraine
Roadmap to BioBucks for Freshly Minted PhDs, MDs & PharmD
Epoch 7 - Worst Day For Biotech Stocks Since November
Epoch 6 - How Much is Your New Biotech Worth? Probably Nothing….
Epoch 6 - Dead Cat Biotech Bounce?
Epoch 5 - Billion Dollar Biotech
Epoch 5 - Cancer is Cured? Biotech Up!
Epoch 4 - From Bench to Business
Epoch 4 - What Goes Down….Can Go Down More
Epoch 3 - Innovate Over Everything...or Not?
Week 3 - Big Fish Eat Little Fish - is M&A the ‘22 Biotech Bailout?
Week 2 - Innate Immune Modulators
Week 2 - Dear Biotech - JPM Will Not Save You This Year…
Week 1 - The Future is Today with Gene Editing / Writing?